Use of urine-based markers for detection and monitoring of bladder cancer

Techniques in Urology

Volumn 5, Issue 4, 1999, Pages 179-184

  Pirtskalaishvili, G ^a   Getzenberg, R H ^a   Konety, B R ^a  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

Bladder cancer; Diagnosis; Urine markers

Indexed keywords

FIBRIN DEGRADATION PRODUCT; TELOMERASE; TUMOR ANTIGEN; TUMOR MARKER;

ANTIGEN DETECTION; BASEMENT MEMBRANE; BLADDER CANCER; CANCER DIAGNOSIS; CELL NUCLEUS MATRIX; CLINICAL TRIAL; CYSTOSCOPY; DIAGNOSTIC TEST; HUMAN; IMMUNOASSAY; LATEX AGGLUTINATION TEST; PATIENT MONITORING; PRIORITY JOURNAL; PROTEIN URINE LEVEL; REVIEW; URINE CYTOLOGY;

ANTIGENS, NEOPLASM; ANTIGENS, NUCLEAR; AUTOANTIGENS; BIOPSY, NEEDLE; CYSTOSCOPY; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; NUCLEAR MATRIX-ASSOCIATED PROTEINS; NUCLEAR PROTEINS; SENSITIVITY AND SPECIFICITY; TELOMERASE; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS; URINE;

EID: 0032748098     PISSN: 10793259     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (43)